Africa’s Biggest Drugmaker Can Help Ease Obesity Medicine Supply Crunch
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Weight loss drugs and the many use cases in medical treatments
Eli Lilly Shares Show Healthy Rise
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
These are the 10 most overvalued stocks in the S&P 500
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
India's Biocon developing its own version of Wegovy, clinical trial likely next year
India's Biocon developing its own version of Wegovy, clinical trial likely next year
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)
Company News for Apr 18, 2024
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY)
Weight-loss drug developer Metsera raises $290 million in funding
Ozempic ‘Oops’ Babies Spark Debate About Weight-Loss Shot Use as Fertility Drugs
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Zoetis (ZTS) and TScan Therapeutics (TCRX)
The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.